-
Journal of Pain Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma
Original Research
(2014) Views (550) Full article downloads
Authors: Andrew Nicolaou, Bruce Nicholson, Guy Hans, et al
Published Date January 2011
Volume 2011:4 Pages 25 - 38
DOI: http://dx.doi.org/10.2147/JPR.S15534
Andrew Nicolaou1, Bruce Nicholson2, Guy Hans3, Louis Brasseur4
1St Georges Hospital, London, UK; 2Allentown, Pennsylvania, USA; 3Antwerp University Hospital, Edegem, Belgium; 4Institut Curie, Saint Cloud, France
Abstract: Five percent lidocaine medicated plaster has been proven efficacious for the symptomatic relief of neuropathic pain in diverse pain conditions which might be attributed to a common localized symptomatology in these indications, possibly with common predictors of treatment success. To discuss potential symptoms and other factors predicting response to treatment with lidocaine plaster for the indications of low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma, 44 pain specialists from 17 countries attended a two-day conference meeting in December 2009. Discussions were based on the retrospective analysis of case reports (sent in by participants in the four weeks prior to the meeting) and the practical experience of the participants. The results indicate some predictors for success with 5% lidocaine medicated plaster for the two indications. Localized pain, hyperalgesia and/or allodynia, and other positive sensory symptoms, such as dysesthesia, were considered positive predictors, whereas widespread pain and negative sensory symptoms were regarded as negative predictors. Paresthesia, diagnosis, and site of pain were considered to be of no predictive value. Common symptomatology with other neurologic pathologies suggests that treatment of localized neuropathic pain symptoms with the plaster can be considered across different neuropathic pain indications.
Keywords: lidocaine plaster, low back pain, surgical and nonsurgical trauma pain, neuropathic pain, case report
Other articles by Professor Guy Hans
Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
Transdermal buprenorphine – a critical appraisal of its role in pain management
Readers of this article also read:
Acute pain management in children
ABO and rhesus blood group distribution in Kurds
Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
Topical preparations for pain relief: efficacy and patient adherence
Facial nerve paralysis and partial brachial plexopathy after epidural blood patch: a case report and review of the literature
Tapentadol extended-release for treatment of chronic pain: a review
Preincisional administration of intravenous or subcutaneous infiltration of low-dose ketamine suppresses postoperative pain after appendectomy
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- An eight-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia
- Problems and barriers of pain management in the emergency department: Are we ever going to get better?
- A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
- Anesthesiologists’ perception of patients’ anxiety under regional anesthesia




